These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 25071337)

  • 81. Vitamin D and calcium: what do we need to know?
    Zhang V; Jiang X; Farukhi YZ; Rosen CJ; Schnatz PF
    Clin Obstet Gynecol; 2013 Dec; 56(4):654-8. PubMed ID: 24047935
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Current options for the management of postmenopausal osteoporosis.
    Lecart MP; Reginster JY
    Expert Opin Pharmacother; 2011 Nov; 12(16):2533-52. PubMed ID: 21916810
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Osteoporosis treatment: a missed opportunity.
    Milat F; Ebeling PR
    Med J Aust; 2016 Aug; 205(4):185-90. PubMed ID: 27510350
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Validity of height loss as a predictor for prevalent vertebral fractures, low bone mineral density, and vitamin D deficiency.
    Mikula AL; Hetzel SJ; Binkley N; Anderson PA
    Osteoporos Int; 2017 May; 28(5):1659-1665. PubMed ID: 28154943
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Osteoporotic fractures: background and prevention strategies.
    Wark JD
    Maturitas; 1996 Mar; 23(2):193-207. PubMed ID: 8735357
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [SECOT-GEIOS guidelines in osteoporosis and fragility fracture. An update].
    Etxebarria-Foronda I; Caeiro-Rey JR; Larrainzar-Garijo R; Vaquero-Cervino E; Roca-Ruiz L; Mesa-Ramos M; Merino Pérez J; Carpintero-Benitez P; Fernández Cebrián A; Gil-Garay E
    Rev Esp Cir Ortop Traumatol; 2015; 59(6):373-93. PubMed ID: 26233814
    [No Abstract]   [Full Text] [Related]  

  • 87. The problem of low levels of vitamin D and osteoporosis: use of combination therapy with alendronic acid and colecalciferol (vitamin D3).
    Epstein S
    Drugs Aging; 2006; 23(8):617-25. PubMed ID: 16964986
    [TBL] [Abstract][Full Text] [Related]  

  • 88. We miss the opportunity: Pretreament of osteoporosis in a German trauma center.
    Rausch V; Schwarzer A; Dietrich JW; Kaisler M; Seybold D; Vollert J; Schildhauer TA; Maier C
    PLoS One; 2018; 13(11):e0207122. PubMed ID: 30418992
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
    Modi A; Tang J; Sen S; Díez-Pérez A
    Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline.
    Shapiro CL; Van Poznak C; Lacchetti C; Kirshner J; Eastell R; Gagel R; Smith S; Edwards BJ; Frank E; Lyman GH; Smith MR; Mhaskar R; Henderson T; Neuner J
    J Clin Oncol; 2019 Nov; 37(31):2916-2946. PubMed ID: 31532726
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Reducing fracture risk with calcium and vitamin D.
    Lips P; Bouillon R; van Schoor NM; Vanderschueren D; Verschueren S; Kuchuk N; Milisen K; Boonen S
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):277-85. PubMed ID: 20796001
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT).
    Sugimoto T; Matsumoto T; Hosoi T; Miki T; Gorai I; Yoshikawa H; Tanaka Y; Tanaka S; Fukunaga M; Sone T; Nakano T; Ito M; Matsui S; Yoneda T; Takami H; Watanabe K; Osakabe T; Okubo N; Shiraki M; Nakamura T
    Osteoporos Int; 2015 Feb; 26(2):765-74. PubMed ID: 25403903
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Value of a coordinated management of osteoporosis via Fracture Liaison Service for the treatment of orthogeriatric patients.
    Schray D; Neuerburg C; Stein J; Gosch M; Schieker M; Böcker W; Kammerlander C
    Eur J Trauma Emerg Surg; 2016 Oct; 42(5):559-564. PubMed ID: 27458065
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Paradoxical Role of Uric Acid in Osteoporosis.
    Lin KM; Lu CL; Hung KC; Wu PC; Pan CF; Wu CJ; Syu RS; Chen JS; Hsiao PJ; Lu KC
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31491937
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Role of nitric oxide in type 1 diabetes-induced osteoporosis.
    Jeddi S; Yousefzadeh N; Kashfi K; Ghasemi A
    Biochem Pharmacol; 2022 Mar; 197():114888. PubMed ID: 34968494
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Applications of Calcium-Based Nanomaterials in Osteoporosis Treatment.
    Deng Y; Wei W; Tang P
    ACS Biomater Sci Eng; 2022 Feb; 8(2):424-443. PubMed ID: 35080365
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Expansion of Bone Precursors through Jun as a Novel Treatment for Osteoporosis-Associated Fractures.
    Lerbs T; Cui L; Muscat C; Saleem A; van Neste C; Domizi P; Chan C; Wernig G
    Stem Cell Reports; 2020 Apr; 14(4):603-613. PubMed ID: 32197115
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Potassium: A Frontier in Osteoporosis.
    Singh W; Kushwaha P
    Horm Metab Res; 2024 May; 56(5):329-340. PubMed ID: 38346690
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Developing siRNA therapies to address osteoporosis.
    Wang Y; Grainger DW
    Ther Deliv; 2013 Oct; 4(10):1239-46. PubMed ID: 24116909
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Bone Diseases in Patients with Chronic Liver Disease.
    Jeong HM; Kim DJ
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.